Medical Device Grade Spider Silk Deemed Not Equivalent To Worm Silk By FDA
This article was originally published in The Gray Sheet
The manufacturing process for creating BioSteel recombinant spider silk sutures will undergo close scrutiny by FDA when developer Nexia Biotechnologies applies for premarket approval
You may also be interested in...
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.
Lilly has launched a similar antibody product, but demand is expected to outpace supply for the foreseeable future.